Divergent epidemic trajectories of ESBL-producing and carbapenemase-producing Enterobacterales in French hospitals: a nationwide modelling study.

Authors

Benjamin Davido, Louise Rouillard, Pierre Leroux, Maelys Durand, Azzam Saleh-Mghir

Published in

The Journal of hospital infection. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Carbapenemase-producing Enterobacterales (CPE) have emerged as a major public health concern despite remaining less frequent than extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E). Conventional surveillance primarily reports annual incidence but provides limited information on epidemic velocity. We compared the epidemic trajectories of ESBL-E and CPE in French hospitals using nationwide surveillance data.
We conducted a nationwide retrospective modelling study using data from the French SPARES surveillance programme (2019-2024). Annual incidence densities (cases per 1,000 patient-days) were analysed using comparative log-linear regression to estimate annual percent change (APC), doubling time and the projected year at which CPE incidence would reach the observed 2024 ESBL-E incidence under unchanged epidemic dynamics. Species distribution and carbapenemase families were also described.
Between 2019 and 2024, ESBL-E incidence remained substantially higher than CPE incidence (0.53-0.70 vs 0.010-0.037 cases per 1,000 patient-days). ESBL-E incidence remained stable over time (APC, 3.1%; P for temporal trend = 0.29), whereas CPE incidence increased significantly faster (APC, 32.8%; P for interaction <0.001), corresponding to estimated doubling times of 23.0 and 2.4 years, respectively. Assuming continuation of current epidemic dynamics, projected CPE incidence would reach the observed 2024 ESBL-E incidence around 2033 (95% CI, 2031-2036). Species distribution differed significantly between ESBL-E and CPE (P<0.001), with Escherichia coli predominating among ESBL-E and Klebsiella pneumoniae among CPE.
Although CPE incidence remains markedly lower than ESBL-E incidence, its epidemic trajectory is substantially steeper. Comparative modelling of epidemic trajectories complements conventional surveillance and may help anticipate future antimicrobial resistance burden while opportunities for infection prevention and antimicrobial stewardship remain.

PMID:
42772692
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.